Nasonex News
Nasonex: Most-Recalled TV Spot of 2007 - PharmExec.com
The Nasonex bee, voiced by Antonio Banderas, was a popular fellow last year. The animated 30-second spot, bested the Rozerum beaver and Chantix's turtle and ...
IAG Research Names Most-Recalled Drug TV Ads - Broadcasting & Cable
Tops in ad-recall scores was Schering-Plough's Nasonex allergy commercial featuring a bee doing an Antonio Banderas impression. No. ...
Bees, Lincoln And Beavers Sell Drugs, Research Firm Finds - Mediapost.com
The Top 5 most-recalled ads were for Schering-Plough's Nasonex, Takeda's Rozerem, Merck/Schering-Plough's Vytorin, Pfizer's Lipitor and Pfizer's Chantix. ...
Yuhan’s prescription drugs in short supply - 데일리팜
We had backorders for Cough Syrup and delays in importing Nasonex due to customs clearance, but other drugs are fine,” said a head of sales support team of ...
Schering-Plough posts $3.4B loss in 4Q on charges related to ... - PR-Inside.com (Pressemitteilung)
Key profit drivers for Schering-Plough include the arthritis treatment Remicade and the allergy treatment Nasonex. Quarterly Remicade sales rose 35 percent ...
Schering-Plough reports steep loss on charges - MarketWatch
Its allergy medication Nasonex saw sales climb 7% to $271 million. Sales of animal health products grew to $507 million from $217 million, helped largely by ...
2nd UPDATE: Schering-Plough Posts 4Q Loss On Purchase Costs - CNNMoney.com
The company markets Remicade in many countries outside the US, while Johnson & Johnson (JNJ) markets it in the US Allergy treatment Nasonex had sales of ...
FUNNY BUSINESS: A primary that matters? In Indiana? Seriously? - Indianapolis Business Journal
It’sa story that takes five seconds to report and comes two thirds of the way into the broadcast, right before the Mucinex, Nasonex and Dulcolax commercials ...
Accounting Changes Send Schering-Plough to a Loss - New York Times
Significant profit sources for Schering-Plough include the arthritis treatment Remicade and the allergy treatment Nasonex. Quarterly Remicade sales rose 35 ...
Schering-Plough Posts $3.4B Loss - The Associated Press
Drugs such as the arthritis treatment Remicade and the allergy treatment Nasonex are among the company's key profit drivers.
Nasonex RSS Feed